Evid Invest
Who owns GILDWhat GILD owns

What GILEAD SCIENCES, INC. owns

The company's own 13F portfolio · as of 2026-06-30 · long US-listed stakes only — private holdings, bonds and cash are not disclosable on a 13F

$1.65B

disclosed stock portfolio

5

positions

58.8%

in RCUS

Positions, as of 2026-06-30

ordered by filed value · % of book = share of the disclosed stock portfolio · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1RCUSArcus Biosciences Inc.31.4M$968.8M58.8%
2LKFTLakefront Biotherapeutics16.7M$500.2M30.3%
3ASMBAssembly Biosciences Inc.5.0M$136.8M8.3%
4KYTXKyverna Therapeutics Inc.4.1M$36.8M2.2%
5Xilio Therapeutics Inc.650,389$6.2M0.4%

Source: SEC Form 13F-HR filed by GILEAD SCIENCES, INC. (CIK 882095), reporting period 2026-06-30. Values are quarter-end filed marks. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.